The characteristics of intravenous adenosine-induced antinociception in a rabbit model of acute nociceptive pain: A comparative study with remifentanil

Anesthesia and Analgesia

Volumn 103, Issue 4, 2006, Pages 1004-1010

  Hayashida, Masakazu ^a   Fukunaga, Atsuo ^b   Fukuda, Ken Ichi ^a   Sakurai, Satoru ^a   Mamiya, Hideki ^a   Ichinohe, Tatsuya ^a   Kaneko, Yuzuru ^a   Hanaoka, Kazuo ^c  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; REMIFENTANIL;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOSE TIME EFFECT RELATION; DRUG TOLERANCE; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PAIN; PRIORITY JOURNAL; RABBIT; SYSTOLIC BLOOD PRESSURE;

ADENOSINE; ANALGESICS; ANALGESICS, OPIOID; ANESTHETICS, INHALATION; ANIMALS; BLOOD PRESSURE; CARBON DIOXIDE; DISEASE MODELS, ANIMAL; HEART RATE; INFUSIONS, INTRAVENOUS; ISOFLURANE; MALE; NOCICEPTORS; PAIN; PAIN MEASUREMENT; PIPERIDINES; RABBITS; RESPIRATION;

EID: 33750070655     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ane.0000237306.05730.ea     Document Type: Article

References (25)

1. Zarate E, Sa Rego MM, White PF, et al. Comparison of adenosine and remifentanil infusions as adjuvants to desflurane anesthesia. Anesthesiology 1999;90:956-63.
2. Fukunaga AF, Alexander GE, Stark CW. Characterization of the analgesic actions of adenosine: comparison of adenosine and remifentanil infusions in patients undergoing major surgical procedures. Pain 2003;101:129-38.
3. Belfrage M, Sollevi A, Segerdahl M, et al. Systemic adenosine infusion alleviate spontaneous and stimulus evoked pain in patients with peripheral neuropathic pain. Anesth Analg 1995;81:713-17.
4. Lynch ME, Clark AJ, Sawynok J. Iv adenosine alleviates neuropathic pain: a double blind placebo controlled crossover trial using an enriched enrolment design. Pain 2003;103:111-17.
5. Michelsen LG, Hug CC Jr. The pharmacokinetics of remifentanil. J Clin Anesth 1996;8:679-82.
6. Hayashida M, Fukunaga A, Hanaoka K. An animal model for surgical anesthesia and analgesia: characterization with isoflurane anesthesia and remifentanil analgesia. Anesth Analg 2003;97:1340-6.
7. Hayashida M, Fukunaga A, Hanaoka K. Detection of acute tolerance to the analgesic and nonanalgesic effects of remifentanil infusion in a rabbit model. Anesth Analg 2003;97:1347-52.
8. Vinik HR, Kissin I. Rapid development of tolerance to analgesia during remifentanil infusion in humans. Anesth Analg 1998;86:1307-11.
9. Sawynok J. Adenosine receptor activation and nociception. Eur J Pharmacol 1998;317:1-11.
10. Sumida T, Smith MA, Maehara Y, et al. Spinal R-phenylisopropyl adenosine inhibits spinal dorsal horn neurons responding to noxious heat stimulation in the absence and presence of sensitization. Pain 1998;74:307-13.
11. Lavand'homme PM, Eisenach JC. Exogenous and endogenous adenosine enhances the spinal antiallodynic effects of morphine in a rat model of neuropathic pain. Pain 1999;80:31-6.
12. Parker RB, McCollam PL. Adenosine in the episodic treatment of paroxysmal supraventricular tachycardia. Clin Pharm 1990;9:261-71.
13. Segerdahl M, Ekblom A, Sandelin K, et al. Peroperative adenosine infusion reduces the requirements for isoflurane and postoperative analgesics. Anesth Analg 1995;80:1145-9.
14. Sjölund KF, Segerdahl M, Sollevi A. Adenosine reduces secondary hyperalgesia in two human models of cutaneous inflammatory pain. Anesth Analg 1999;88:605-10.
15. Rane K, Segerdahl M, Goiny M, et al. Intrathecal adenosine administration: a phase I clinical safety study in healthy volunteers, with additional evaluation of its influence on sensory thresholds and experimental pain. Anesthesiology 1998;89:1108-15.
16. Eisenach JC, Hood DD, Curry R. Preliminary efficacy assessment of intrathecal injection of an Am formulation of adenosine in humans. Anesthesiology 2002;96:29-34.
17. Segerdahl M, Sollevi A. Adenosine and pain relief: a clinical overview. Drug Dev Res 1998;45:151-8.
18. Rane K, Sollevi A, Segerdahl M. Intrathecal adenosine administration in abdominal hysterectomy lacks analgesic effect. Acta Anaesthesiol Scand 2000;44:868-72.
19. Rane K, Sollevi A, Segerdahl M. A randomized double-blind evaluation of adenosine as adjunct to sufentanil in spinal labour analgesia. Acta Anaesthesiol Scand 2003;47:601-3.
20. Hayashida M, Fukunaga A, Fukuda K, et al. Does IV adenosine really exert an antinociceptive effect? In: Hanaoka K, Yuge O, Namika A, eds. Proceedings of the 11th International Pain Clinic World Society of Pain Clinicians. Bologna, Italy: Medimond, 2004:475-8.
21. Hood DD, Curry R, Eisenach JC. IV remifentanil produces withdrawal hyperalgesia in volunteers with capsaicin-induced hyperalgesia. Anesth Analg 2003;97:810-5.
22. Fukunaga AF, Flacke WE, Bloor BC. Hypotensive effects of adenosine and adenosine triphosphate compared with sodium nitroprusside. Anesth Analg 1982;61:273-8.
23. Tamai I, Tsuji A. Transporter-mediated permeation of drugs across the blood-brain barrier. J Pharm Sci 2000;89:1371-88.
24. Karlsten R, Gordh T Jr. An A1-selective adenosine agonist abolishes allodynia elicited by vibration and touch after intrathecal injection. Anesth Analg 1995;80:844-7.
25. Fukunaga AF. Adenosine compounds. In: White PF, ed. Textbook of IV anesthesia. Baltimore: Williams & Wilkins, 1997:413-32.